Jessica A. Bush

Jessica A. Bush

Auto-generated profile, based on publicly available information

Jessica A. Bush

Department of Chemistry, The Scripps Research Institute and UF Scripps Biomedical Research, University of Florida, Jupiter, FL 33458

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
JBJessica A. Bush
Jessica A. Bush
HAHaruo Aikawa
Haruo Aikawa
RFRita Fuerst
Rita Fuerst
YLYue Li
Yue Li
AUAndrei Ursu
Andrei Ursu
MDMatthew D. Disney
Matthew D. Disney
Small-molecule recruitment of an endogenous nuclease rescues pathologies associated with c9ALS/FTD in vivo by targeting an RNA repeat expansion.

21 November 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JBJessica A. Bush
Jessica A. Bush
SMSamantha M. Meyer
Samantha M. Meyer
RFRita Fuerst
Rita Fuerst
YTYuquan Tong
Yuquan Tong
YLYue Li
Yue Li
MDMatthew D. Disney
Matthew D. Disney
A hexanucleotide repeat expansion in intron 1 of the C9orf72 gene is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia, or c9ALS/FTD. The RNA transcribed from the expansion, r(G 4 C 2 ) exp , causes various pathologies, including intron retention, aberrant translation that produces toxic dipeptide repeat proteins (DPRs), and sequestration of RNA-binding proteins (RBPs) in RNA foci. Here, we describe a small molecule that potently and selectively interacts with r(G 4 C 2 ) exp and mitigates disease pathologies in spinal neurons differentiated from c9ALS patient-derived induced pluripotent stem cells (iPSCs) and in two c9ALS/FTD mouse models. These studies reveal a mode of action whereby a small molecule diminishes intron retention caused by the r(G 4 C 2 ) exp and allows the liberated intron to be eliminated by the nuclear RNA exosome, a multi-subunit degradation complex. Our findings highlight the complexity of mechanisms available to RNA-binding small molecules to alleviate disease pathologies and establishes a pipeline for the design of brain penetrant small molecules targeting RNA with novel modes of action in vivo.